Data from Detection of BRCA1, BRCA2, and ATM Alterations in Matched Tumor Tissue and Circulating Tumor DNA in Patients with Prostate Cancer Screened in PROfound

MLA

Elizabeth A. Harrington, et al. Data from Detection of BRCA1, BRCA2, and ATM Alterations in Matched Tumor Tissue and Circulating Tumor DNA in Patients with Prostate Cancer Screened in PROfound. Apr. 2023. EBSCOhost, https://doi.org/10.1158/1078-0432.c.6532970.v1.

APA

Elizabeth A. Harrington, Antoine Thiery-Vuillemin, David Olmos, Joaquin Mateo, Johann de Bono, Arun Azad, Neeraj Agarwal, Geoffrey R. Oxnard, Simon Dearden, Ashley Easter, Ping Qiu, Carrie A. Adelman, J. Carl Barrett, Claire Corcoran, Zhongwu Lai, Caroline Sibilla, Alan Barnicle, & Kim N. Chi. (2023). Data from Detection of BRCA1, BRCA2, and ATM Alterations in Matched Tumor Tissue and Circulating Tumor DNA in Patients with Prostate Cancer Screened in PROfound. https://doi.org/10.1158/1078-0432.c.6532970.v1

Chicago

Elizabeth A. Harrington, Antoine Thiery-Vuillemin, David Olmos, Joaquin Mateo, Johann de Bono, Arun Azad, Neeraj Agarwal, et al. 2023. “Data from Detection of BRCA1, BRCA2, and ATM Alterations in Matched Tumor Tissue and Circulating Tumor DNA in Patients with Prostate Cancer Screened in PROfound,” April. doi:10.1158/1078-0432.c.6532970.v1.